Skin was divided into dermis and epidermis (on ice, by scalpel, with the aid of visual inspection at ×40 magnification) as previously described (17 (link), 20 (link)). Skin (5–30 mg) and plasma samples (∼1 ml) were extracted using ice-cold methanol (15%, v/v), and 12-hydroxyeicosatetraenoic acid (HETE)-d8, prostaglandin (PG)B2-d4, 8 (9)-epoxy eicosatrienoic acid-d11, and 8,9-dihydroxyeicosatrienoic acid-d11 (20 ng each/sample; Cayman Chemicals, Ann Arbor, MI, USA) were used as internal standards. The extracts were semipurified using solid-phase extraction cartridges (C18-E; Phenomenex, Macclesfield, United Kingdom) to eliminate matrix effects. Ultraperformance liquid chromatography with electrospray ionization and tandem mass spectrometry (UPLC/ESI-MS/MS) analysis was performed on an Acquity UPLC pump (Waters, Wilmslow, United Kingdom) coupled to an electrospray ionization triple quadrupole mass spectrometer (Xevo TQ-S; Waters) as previously described (17 (link), 31 (link), 32 (link)). A detailed list of the multiple reaction monitoring transitions and collision energy settings is provided in Supplemental Table S1. Results are expressed as picograms per milligram protein (skin) or picograms per milliliter (plasma).
Free full text: Click here